CRT 2026
Disparities in Interventional Cardiology
Joaquin E. Cigarroa, MD
Director, Knight Cardiovascular Institute
OHSU Knight Cardiovascular Institute
Portland, Oregon, United States
Disclosure(s): No financial relationships to disclose
Michele D. Voeltz, MD, FACC, FSCAI
Attending Physician
Northside Cardiovascular Institute
Buford, Georgia, United States
Disclosure(s): No financial relationships to disclose
Kim Allan Williams, Sr., MD, MACC, FAHA, MASNC, FESC
Chair, Department of Medicine
University of Louisville
Louisville, Kentucky, United States
Disclosure(s): No financial relationships to disclose
Jennifer L. Carter, DPT
Senior Physical Therapist
Medstar Washington Hospital Center
Silver Spring, Maryland, United States
Disclosure(s): No financial relationships to disclose
Sara D. Collins, MD
Medical Director
Flourish Research Bowie
Bowie, Maryland, United States
Disclosure(s): Amgen: Consulting Fees (e.g., advisory boards) (Ongoing); Eli Lilly & Company: Consulting Fees (e.g., advisory boards) (Ongoing); Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing)
Foluso A. Fakorede, MD
CEO
Cardiovascular Solutions Of Central Mississippi-Fusion Vascular
Grenada , Mississippi, United States
Disclosure(s): No financial relationships to disclose
Ramesh Mazhari, MD, MBA
Professor of Medicine, Director of Cardiovascular ICU
George Washington University, District of Columbia, United States
Disclosure(s): No financial relationships to disclose
Craig M. Walker, MD
Chief Medical Director/President/Founder
Cardiovascular Institute of the South
Gray, Louisiana, United States
Disclosure(s): No financial relationships to disclose